Abstract

BackgroundSudden cardiac death (SCD) and pump failure death (PFD) are common endpoints in chronic heart failure (CHF) patients, but prevention strategies are different. Currently used tools to specifically predict these endpoints are limited. We developed risk models to specifically assess SCD and PFD risk in CHF by combining ECG markers and clinical variables.MethodsThe relation of clinical and ECG markers with SCD and PFD risk was assessed in 597 patients enrolled in the MUSIC (MUerte Súbita en Insuficiencia Cardiaca) study. ECG indices included: turbulence slope (TS), reflecting autonomic dysfunction; T-wave alternans (TWA), reflecting ventricular repolarization instability; and T-peak-to-end restitution (ΔαTpe) and T-wave morphology restitution (TMR), both reflecting changes in dispersion of repolarization due to heart rate changes. Standard clinical indices were also included.ResultsThe indices with the greatest SCD prognostic impact were gender, New York Heart Association (NYHA) class, left ventricular ejection fraction, TWA, ΔαTpe and TMR. For PFD, the indices were diabetes, NYHA class, ΔαTpe and TS. Using a model with only clinical variables, the hazard ratios (HRs) for SCD and PFD for patients in the high-risk group (fifth quintile of risk score) with respect to patients in the low-risk group (first and second quintiles of risk score) were both greater than 4. HRs for SCD and PFD increased to 9 and 11 when using a model including only ECG markers, and to 14 and 13, when combining clinical and ECG markers.ConclusionThe inclusion of ECG markers capturing complementary pro-arrhythmic and pump failure mechanisms into risk models based only on standard clinical variables substantially improves prediction of SCD and PFD in CHF patients.

Highlights

  • Sudden cardiac death (SCD) and pump failure death (PFD) are both common endpoints in patients with chronic heart failure (CHF) [1]

  • Univariable Cox analyses showed that the only clinical variable significantly associated with SCD in the HFrEF group was administration of ARB or ACE inhibitors (S2 Table)

  • Univariable Cox analyses showed that no clinical variable was significantly associated with SCD or PFD (S2 and S3 Tables)

Read more

Summary

Introduction

Sudden cardiac death (SCD) and pump failure death (PFD) are both common endpoints in patients with chronic heart failure (CHF) [1]. Prevention of these two different modes of death requires different treatment, including implantable cardioverter defibrillators (ICDs) to reduce SCD mortality [2] and cardiac resynchronization therapy to decrease PFD rate [3]. A common finding in CHF patients is chronic sympathetic over-activity [5], a risk factor for both SCD and PFD [6, 7]. Sudden cardiac death (SCD) and pump failure death (PFD) are common endpoints in chronic heart failure (CHF) patients, but prevention strategies are different. We developed risk models to assess SCD and PFD risk in CHF by combining ECG markers and clinical variables

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call